Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0928 in Elderly Patients With Primary Insomnia
NCT00094666Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Nov 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Insomnia comparing Gaboxadol with Placebo (2 arms). Primary endpoints: Wake After Sleep Onset at 2 days and Latency to Persistent Sleep at 2 days. Started Nov 2004; status: terminated.
02
Drugs
gaboxadol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00094666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00094666.